Exemestane in Hormone Receptor Positive High Grade Ovarian Cancer
Condition(s):Ovarian CancerLast Updated:February 12, 2024Terminated
Hide Studies Not Open or Pending
Condition(s):Ovarian CancerLast Updated:February 12, 2024Terminated
Condition(s):Breast CancerLast Updated:April 27, 2023Active, not recruiting
Condition(s):Breast Cancer; Estrogen Receptor-Positive Breast Cancer; Breast Cancer, Estrogen Receptor-Positive; ER+ Breast CancerLast Updated:May 11, 2022Completed
Condition(s):Breast CancerLast Updated:August 3, 2012Unknown status
Condition(s):Breast Cancer; Estrogen Receptor Positive Breast CancerLast Updated:December 15, 2021Completed
Condition(s):Locally Advanced Breast Cancer; Metastatic Breast CancerLast Updated:February 24, 2015Completed
Condition(s):Breast NeoplasmsLast Updated:March 25, 2019Completed
Condition(s):Breast NeoplasmsLast Updated:February 25, 2010Completed
Condition(s):Breast CancerLast Updated:January 23, 2018Completed
Condition(s):Breast CancerLast Updated:January 23, 2018Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.